期刊文献+

希罗达联合艾素治疗晚期乳腺癌的临床观察 被引量:3

Clinical observation on docetaxel combined with xeloda in treatment of advanced breast cancer
下载PDF
导出
摘要 目的:研究希罗达联合艾素方案治疗晚期乳腺癌的近期疗效及毒副反应。方法:51例晚期乳腺癌患者,均经病理组织学证实。治疗方案希罗达1250mg/m2日两次口服d1~14,艾素35mg/m2静脉滴注d1,8,21天1周期,至少2周期评价疗效。结果:51例中完全缓解(CR)3例,部分缓解(PR)22例,无变化(NC)16例,进展(PD)10例,总有效率(RR)49.01%,1年生存率78.26%。毒副反应主要为骨髓抑制,消化道反应,可耐受。结论:希罗达联合艾素治疗晚期乳腺癌疗效肯定,毒副反应小,是治疗晚期乳腺癌较好方案,值得临床推广。 To evaluate the efficacy and toxicity of docetaxel combined with xeloda in the treatment of patients with advanced breast cancer. Methods: Fifty - one patients with advanced breast cancer diagnosed pathologically were enrolled into the study. The patients received xeloda 2500mg/m^2 , on day 1 - 14 ; and docetaxel 35mg/m^2 ,on day 1,8. The chemotherapy was repeated every 21 days. All the patients received at least 2 cycles. Resuits: Objective response was obtained in 49.01% of patients( 3 complete and 22 partial responses) whereas 16 patients had no change and 10 patients were progressive,and 1 - year survival rate was 78.26%. The main toxicities included myelosuppression ,nausea, vomiting . Conclusion: Docetaxel combined with xeloda is effective in the treatment of advanced breast cancer , with mild or moderate side effects.
作者 张咏梅 张捷
出处 《现代肿瘤医学》 CAS 2007年第11期1588-1589,共2页 Journal of Modern Oncology
关键词 晚期乳腺癌 希罗达 艾素 advanced breast cancer docetaxel xeloda
  • 相关文献

参考文献5

  • 1孙燕 周际昌.临床肿瘤内科手册[M].北京:人民卫生出版社,2003.586-591.
  • 2汤钊猷.现代肿瘤学[M].上海:上海医科大学出版社,2002.820.
  • 3Ferlini C,scambia G , Distefano M, et al. Synergistic antiproliferative activity of tamoxifen and docetaxel' on three oestrogen receptor - negative cancer cell lines is mediated by the induction of apoptosis[J]. Br J Cancer, 1997,75 (6) :884 -891.
  • 4Fossella FV. Docetaxel in the treatment of non - small cell lung cancer :review of single -agent trials [J]. Semin Oncol, 1999, 26 (5 Suppl 16) :17 -23.
  • 5Miwa M , Nishida M , et al. Design of a novel oral fluoropyrimidine carbamate , capecitabine , which generates 5 - fluorouracil selectively in tumours by enzymes concertrated in human liver and cancer tissue [J]. Eur J Cancer, 1998, 34 : 1274 - 1281.

共引文献390

同被引文献15

引证文献3

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部